Ultomiris (ravulizumab)

pCPA File Number: 22965
Negotiation Status:
Active Negotiation
Indication(s):
Generalized myasthenia gravis (gMG)
Sponsor/Manufacturer:
Alexion Pharma GmbH
CDA-AMC Project Number:
SR0855-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable